Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (2), 438-443
- https://doi.org/10.1016/s0735-1097(00)00736-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yetThe American Journal of Cardiology, 1999
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.Circulation, 1994
- B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurementsAtherosclerosis, 1993
- EFFECT OF PERINDOPRIL ON THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE CHOLESTEROL-FED RABBITClinical and Experimental Pharmacology and Physiology, 1992
- Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.Circulation, 1992
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Effects of Captopril on Atherosclerosis in Cynomolgus MonkeysJournal of Cardiovascular Pharmacology, 1990
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989